Formulation And Evaluation Of Biodegradable Microspheres For Controlled Release Of Glibenclamide

Authors

  • Rajiv Yadava
  • Durga Prameela. Gaddam
  • Rohitashav Sharma
  • Urmila Rathore
  • Kavita Shukla
  • Ramenani Hari Babu
  • Pooja Arora
  • Jeevan Patel
  • Chandan Kumar Brahma

Keywords:

Biodegradable Polymers, Controlled Drug Delivery, Ethyl Cellulose, Floating Microspheres, Glibenclamide, Ionic Gelation, Mucoadhesive Polymers, Particle Size, PLGA, Sustained Release, Swelling Index

Abstract

The development of sustained-release drug delivery systems, particularly biodegradable microspheres, offers a promising approach to enhance the therapeutic efficacy and patient compliance for drugs like Glibenclamide, which traditionally requires frequent dosing due to its short elimination half-life (Rashmi R Kokardekar et al., 2015). Glibenclamide, an oral anti-hyperglycemic agent for non-insulin-dependent diabetes mellitus, can benefit significantly from controlled release formulations that overcome issues such as the "all or nothing" effect and non-uniform drug release associated with conventional extended-release single-unit dosage forms (Rashmi R Kokardekar et al., 2015). Microspheres, ranging from 1 to 1000 µm, are multi-particulate drug carrier systems designed to improve drug bioavailability and minimize side effects by providing a constant and prolonged therapeutic effect, or by targeting specific sites (Prashant Singh & Ritu M. Gilgotra, 2020). This research investigates the formulation and evaluation of biodegradable Glibenclamide microspheres, focusing on their physicochemical properties, drug entrapment efficiency, and in-vitro release kinetics. Various methods have been employed for preparing biodegradable microspheres containing Glibenclamide, primarily aiming for sustained drug release and enhanced patient adherence. For instance, Simvastatin-loaded PLGA microspheres were prepared using an oil-in-water emulsion/solvent evaporation method, demonstrating its applicability for controlled release systems (*Email: jafarzattums.ac.ir, 2016). In the context of Glibenclamide, studies have utilized emulsion-solvent evaporation with polymers

 

like Ethyl Cellulose N100, a water-insoluble polymer known for its biocompatibility, stability, ease of fabrication, and cost-effectiveness, to achieve sustained release for up to 24 hours (Rashmi R Kokardekar et al., 2015). This method involves dissolving the drug and polymer in a suitable solvent, which is then dispersed into an encapsulating medium, allowing the solvent to evaporate and form solid microspheres (Prashant Singh & Ritu M. Gilgotra, 2020).

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Sahoo, S. K., Behera, S., & et al. (2012). Preparation and evaluation of glibenclamide-loaded poly(lactic-co-glycolic) acid nanoparticles. Tropical Journal of Pharmaceutical Research, 11(3), 345–350.

[In Situ Forming Microparticles]. (2021). Long term delivery of glibenclamide from in situ forming microparticles for the treatment of ischemic stroke. Journal, Issue(?), pages.

Kumar, L., & Meel, R. K. (2022). Formulation and evaluation of floating microspheres of glibenclamide using muco adhesive polymers by ion gelation method. Journal of Drug Delivery and Therapeutics, 12(1), 136–141.

Venkateswarlu, K. (2017). Evaluation of glibenclamide microspheres for sustained release. Journal of Pharmacy & Pharmacognosy Research, 5(2), 78–87.

[IJPSR Study]. (2012). Formulation and in vitro evaluation of sustained released glibenclamide microspheres using Eudragit RS 100. Indian Journal of Pharmaceutical Sciences and Research, 3(?).

[RJPT Study]. (YYYY). Formulation development and evaluation of glibenclamide. Research Journal of Pharmacy & Technology.

[Zenodo]. (2017). Formulation and evaluation of microspheres. Zenodo.

[PMC Review]. (2022). PLGA-based biodegradable microspheres in drug delivery. PMC, Article.

[Bioline Study]. (2017). Preparation and evaluation of glibenclamide-loaded PLGA nanoparticles. Bioline International.

[Impactfactor Study]. (2025). Design, development, and evaluation of alginate-chitosan microspheres. IJPQA.

Chakraborty, A. (2018). Formulation and evaluation of glibenclamide microsphere drug delivery system. SlideShare Presentation.

[Controlled Release Silica Study]. (2018). Controlled release of glibenclamide from monolithic silica. Journal of Controlled Release.

[Polyester Microparticles]. (2021). Formulation, assessment, and compatibility analysis of different polymers loaded microspheres. Journal.

[ResearchGate ISFM]. (2021). Long-term delivery of glibenclamide from in situ forming microparticles. ResearchGate Article.

Chakraborty, A. (2018). Glibenclamide microspheres using agar by spray congealing. SlideShare Presentation.

Downloads

Published

2025-07-09

How to Cite

1.
Yadava R, Gaddam DP, Sharma R, Rathore U, Shukla K, Babu RH, Arora P, Patel J, Brahma CK. Formulation And Evaluation Of Biodegradable Microspheres For Controlled Release Of Glibenclamide. J Neonatal Surg [Internet]. 2025Jul.9 [cited 2025Sep.21];14(32S):4619-28. Available from: https://jneonatalsurg.com/index.php/jns/article/view/8169